Brief: Guided Therapeutics Signs Agreement To Begin Clinical Trial For Us FDA Approval
21/12/2022 14:07
Dec 21 (Reuters) - Guided Therapeutics Inc GTHP.PK :
* GUIDED THERAPEUTICS SIGNS AGREEMENT TO BEGIN CLINICAL
TRIAL FOR
US FDA APPROVAL
Source text for Eikon: ID:nBw7Gx1l8a
Further company coverage: GTHP.PK
((Reuters.Briefs@thomsonreuters.com))
Recent news on Guided Therapeutics
See all newsBrief: Guided Therapeutics Receives $700,000 Purchase Order And Initial Payment From New Chinese Distributor
Brief: Guided Therapeutics Signs Agreement To Begin Clinical Trial For Us FDA Approval
Brief: Guided Receives IRB Approval To Start Clinical Study For FDA Approval Of Luviva Advanced Cervical Scan
Brief: Guided Therapeutics Inc Have Applied To List Common Stock On Nasdaq Capital Market
Brief: Guided Therapeutics Says Replaces Convertible Note Facility And Significantly Reduces Dilution